Joe Papa, Emergent BioSolutions CEO
May 2, 2024 11:37 AM EDTUpdated 01:41 PM
Manufacturing

Emer­gent to shut fa­cil­i­ties and lay off work­ers as part of new CEO’s roadmap

Anna Brown

News Reporter

New­ly ap­point­ed CEO Joe Pa­pa out­lined his vi­sion for Emer­gent BioSo­lu­tions, which in­cludes wind­ing down two fa­cil­i­ties and lay­ing off 300 em­ploy­ees to save …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times